During clinical trials the overall adverse event profile of NovoLog® Mix 50/50 was comparable to Novolin® 70/30. Adverse events commonly associated with human insulin therapy include the following: Body as whole:allergic reactions(seePRECAUTIONS,Allergy). Skin and Appendages:Injection site reacti...
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product. Reference products These are biological products that have already been approved by the FDA, against which biosimilar products are compared. Th...